| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GILD | Common Stock | +Grant/Award | $0 | +2,310 | +20.97% | $0.00 | 13,324 | May 8, 2024 | Direct | F1 |
| transaction | GILD | Common Stock | -Tax liability | -$29,279 | -451 | -3.38% | $64.92 | 12,873 | May 8, 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GILD | Non-qualified Stock Option (Right to Buy) | +Grant/Award | $0 | +12,648 | $0.00 | 12,648 | May 8, 2024 | Common Stock | 12,648 | $64.92 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Represents 2,310 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of May 8, 2024. |
| F2 | 100% of the shares subject to the stock option vested immediately upon the grant date of May 8, 2024. |